MiNK Therapeutics Inc.

8.50
-0.45 (-5.03%)
At close: Mar 03, 2025, 3:58 PM
8.79
3.44%
After-hours: Mar 03, 2025, 03:58 PM EST

MiNK Therapeutics Ratios Statement

Year FY23 FY22 FY21 FY20 FY19
PE Ratio -16.37 -35.47 -64.6 -253.24 -153.22
PEG Ratio 1.35 -4.89 -1.38 6.37 n/a
PS Ratio n/a 0.32 n/a n/a 5.76K
PB Ratio -20.36 -2.19K 62.80 -73.7 -109.28
P/FCF Ratio -23.22 -45.97 -114.18 -470.83 -258.31
P/OCF Ratio -23.32 -46.58 -116.4 -476.2 -265.68
OCF/S Ratio n/a -0.01 n/a n/a -21.67
Debt / Equity Ratio n/a n/a n/a -0.81 -0.74
Quick Ratio 0.32 1.61 2.41 0.22 0.11
Current Ratio 0.32 1.61 2.41 0.29 0.12
Asset Turnover n/a 125.97 n/a n/a 0.53
Interest Coverage n/a -122.17 -11.66 -6 -14.28
Return on Equity (ROE) 1.24 61.75 -0.97 0.29 0.71
Return on Assets (ROA) -4.93 -1.15 -0.57 -3.44 -19.8
Return on Capital (ROIC) 3.35 -3.52 -1.19 1.51 3.65
Dividend Yield n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a
Gross Profit Margin n/a -1.04K% n/a n/a 100.00%
Net Profit Margin n/a -0.92% n/a n/a -3.76K%
Pretax Profit Margin n/a -1.03% n/a n/a -3.45K%
Operating Profit Margin n/a -1.14% n/a n/a -3.23K%
FCF Margin n/a -0.71% n/a n/a -2.23K%
EBITDA Margin n/a -1.14% n/a n/a -3.22K%